Merck Net Income 2012-2025 | MKKGY

Merck annual/quarterly net income history and growth rate from 2012 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.

Merck net income for the quarter ending September 30, 2025 was $1.054B, a 18.52% increase year-over-year.
Merck net income for the twelve months ending September 30, 2025 was $3.277B, a 11.97% increase year-over-year.
Merck annual net income for 2024 was $3.005B, a 1.68% decline from 2023.
Merck annual net income for 2023 was $3.056B, a 12.78% decline from 2022.
Merck annual net income for 2022 was $3.504B, a 3.05% decline from 2021.

Merck Annual Net Income (Millions of US $)
2024	$3,005
2023	$3,056
2022	$3,504
2021	$3,614
2020	$2,270
2019	$1,478
2018	$3,985
2017	$2,939
2016	$1,803
2015	$1,237
2014	$1,548
2013	$1,606
2012	$745
2011	$876

Merck Quarterly Net Income (Millions of US $)
2025-09-30	$1,054
2025-06-30	$740
2025-03-31	$774
2024-12-31	$708
2024-09-30	$890
2024-06-30	$654
2024-03-31	$753
2023-12-31	$630
2023-09-30	$804
2023-06-30	$768
2023-03-31	$854
2022-12-31	$664
2022-09-30	$930
2022-06-30	$923
2022-03-31	$988
2021-12-31	$919
2021-09-30	$897
2021-06-30	$898
2021-03-31	$901
2020-12-31	$506
2020-09-30	$941
2020-06-30	$319
2020-03-31	$503
2019-12-31	$353
2019-09-30	$381
2019-06-30	$529
2019-03-31	$215
2018-12-31	$2,876
2018-09-30	$395
2018-06-30	$295
2018-03-31	$419
2017-12-31	$1,162
2017-09-30	$758
2017-06-30	$463
2017-03-31	$555
2016-12-31	$288
2016-09-30	$510
2016-06-30	$352
2016-03-31	$652
2015-12-31	$138
2015-09-30	$407
2015-06-30	$380
2015-03-31	$321
2014-12-31	$313
2014-09-30	$331
2014-06-30	$405
2014-03-31	$446
2013-12-31	$382
2013-09-30	$450
2013-06-30	$419
2013-03-31	$345
2012-12-31	$350
2012-09-30	$232
2012-06-30	$-78
2012-03-31	$222
2011-12-31	$178
2011-09-30	$321
2011-06-30	$-124
2011-03-31	$466

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$19.360B	$22.569B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$87.245B	33.14
Zoetis (ZTS)	United States	$54.919B	19.66
Takeda Pharmaceutical (TAK)	Japan	$50.943B	10.40
Daiichi Sankyo, - (DSNKY)	Japan	$42.301B	21.07
BeOne Medicines - (ONC)	Switzerland	$38.498B	204.10
Sandoz Group AG (SDZNY)	Switzerland	$32.476B	0.00
United Therapeutics (UTHR)	United States	$20.532B	18.07
Shionogi (SGIOY)	Japan	$15.432B	14.17
Neurocrine Biosciences (NBIX)	United States	$13.187B	31.64
Summit Therapeutics (SMMT)	United States	$12.963B	0.00
Ionis Pharmaceuticals (IONS)	United States	$12.874B	0.00
IPSEN (IPSEY)	France	$12.596B	0.00
Madrigal Pharmaceuticals (MDGL)	United States	$11.217B	0.00
Orion OYJ (ORINY)	Finland	$10.204B	29.15
Eisai (ESAIY)		$8.586B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$6.576B	20.00
Stevanato Group S.p.A (STVN)	Italy	$6.178B	34.58
Grifols, S.A (GRFS)	Spain	$6.078B	0.00
Crinetics Pharmaceuticals (CRNX)	United States	$5.154B	0.00
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.613B	0.00
Indivior (INDV)	United States	$4.251B	17.35
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$4.077B	19.36
Corcept Therapeutics (CORT)	United States	$3.824B	41.31
NewAmsterdam Pharma (NAMS)	Netherlands	$3.613B	0.00
Centessa Pharmaceuticals (CNTA)	United Kingdom	$2.987B	0.00
Hypermarcas (HYPMY)	Brazil	$2.784B	19.11
Catalyst Pharmaceuticals (CPRX)	United States	$2.747B	8.76
Dyne Therapeutics (DYN)	United States	$2.434B	0.00
Soleno Therapeutics (SLNO)	United States	$2.230B	0.00
Ocular Therapeutix (OCUL)	United States	$2.222B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$2.098B	0.00
Guardian Pharmacy Services (GRDN)	United States	$1.979B	38.12
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$1.976B	23.42
Harrow (HROW)	United States	$1.748B	107.25
Ardelyx (ARDX)	United States	$1.711B	0.00
Enliven Therapeutics (ELVN)	United States	$1.528B	0.00
Oruka Therapeutics (ORKA)	United States	$1.517B	0.00
Collegium Pharmaceutical (COLL)	United States	$1.495B	7.40
BioCryst Pharmaceuticals (BCRX)	United States	$1.422B	84.38
Amylyx Pharmaceuticals (AMLX)	United States	$1.384B	0.00
Relay Therapeutics (RLAY)	United States	$1.376B	0.00
Evotec AG (EVO)	Germany	$1.374B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.279B	0.00
Savara (SVRA)	United States	$1.205B	0.00
ARS Pharmaceuticals (SPRY)	United States	$1.118B	0.00
Cronos Group (CRON)	Canada	$1.032B	0.00
Theravance Biopharma (TBPH)	United States	$1.030B	43.26
Xencor (XNCR)	United States	$0.995B	0.00
Esperion Therapeutics (ESPR)	United States	$0.789B	0.00
KalVista Pharmaceuticals (KALV)	United States	$0.755B	0.00
Ironwood Pharmaceuticals (IRWD)	United States	$0.755B	17.85
Nektar Therapeutics (NKTR)	United States	$0.744B	0.00
Rigel Pharmaceuticals (RIGL)	United States	$0.689B	6.15
ProKidney (PROK)	United States	$0.689B	0.00
Bioventus (BVS)	United States	$0.637B	13.05
Lexeo Therapeutics (LXEO)	United States	$0.542B	0.00
Organogenesis (ORGO)	United States	$0.518B	0.00
Elite Pharmaceuticals (ELTP)	United States	$0.516B	0.00
Lyell Immunopharma (LYEL)	United States	$0.504B	0.00
Zevra Therapeutics (ZVRA)	United States	$0.502B	0.00
Siga Technologies (SIGA)	United States	$0.473B	6.47
4D Molecular Therapeutics (FDMT)	United States	$0.449B	0.00
Altimmune (ALT)	United States	$0.418B	0.00
Aquestive Therapeutics (AQST)	United States	$0.417B	0.00
Nature's Sunshine Products (NATR)	United States	$0.392B	23.34
USANA Health Sciences (USNA)	United States	$0.371B	10.36
Akebia Therapeutics (AKBA)	United States	$0.366B	0.00
Avalo Therapeutics (AVTX)	United States	$0.318B	0.00
Profound Medical (PROF)	Canada	$0.304B	0.00
Relmada Therapeutics (RLMD)	United States	$0.298B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.294B	0.00
Aclaris Therapeutics (ACRS)	United States	$0.294B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.279B	0.00
Larimar Therapeutics (LRMR)	United States	$0.276B	0.00
Fractyl Health (GUTS)	United States	$0.275B	0.00
OmniAb (OABI)	United States	$0.274B	0.00
Heron Therapeutics (HRTX)	United States	$0.271B	0.00
Protara Therapeutics (TARA)	United States	$0.254B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.249B	0.00
Journey Medical (DERM)	United States	$0.217B	0.00
Enlivex Therapeutics (ENLV)	Israel	$0.210B	0.00
Galectin Therapeutics (GALT)	United States	$0.198B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.190B	0.00
Century Therapeutics (IPSC)	United States	$0.188B	0.00
Minerva Neurosciences (NERV)	United States	$0.185B	0.00
MediWound (MDWD)	Israel	$0.183B	0.00
Innate Pharma SA (IPHYF)	France	$0.181B	0.00
Surrozen (SRZN)	United States	$0.177B	0.00
AleAnna (ANNA)	United States	$0.168B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.161B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.145B	0.00
Prelude Therapeutics (PRLD)	United States	$0.141B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.139B	0.00
Context Therapeutics (CNTX)	United States	$0.138B	0.00
Incannex Healthcare (IXHL)	Australia	$0.132B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.130B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.128B	0.00
VAXART, INC (VXRT)	United States	$0.127B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.126B	0.00
Pyxis Oncology (PYXS)	United States	$0.117B	0.00
Avita Medical (RCEL)	United States	$0.101B	0.00
Cassava Sciences (SAVA)	United States	$0.099B	0.00
Champions Oncology (CSBR)	United States	$0.098B	41.50
Cardiol Therapeutics (CRDL)	Canada	$0.097B	0.00
Vivani Medical (VANI)	United States	$0.093B	0.00
Gain Therapeutics (GANX)	United States	$0.086B	0.00
Korro Bio (KRRO)	United States	$0.085B	0.00
PolyPid (PYPD)	Israel	$0.070B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.070B	58.50
Dominari Holdings (DOMH)	United States	$0.068B	0.00
Assertio Holdings (ASRT)	United States	$0.066B	0.00
Plus Therapeutics (PSTV)	United States	$0.065B	0.00
Arch Biopartners (ACHFF)	Canada	$0.065B	0.00
Metagenomi (MGX)	United States	$0.065B	0.00
Rafael Holdings (RFL)	United States	$0.064B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.063B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.062B	0.00
Lipocine (LPCN)	United States	$0.058B	0.00
Lite Strategy (LITS)	United States	$0.055B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.054B	0.00
Nutriband (NTRB)	United States	$0.052B	0.00
ElectroCore (ECOR)	United States	$0.050B	0.00
Talphera (TLPH)	United States	$0.048B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.046B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.041B	0.00
FibroGen (FGEN)	United States	$0.039B	0.00
Wellgistics Health (WGRX)	United States	$0.038B	0.00
FibroGen (KYNB)	United States	$0.037B	0.00
Mural Oncology (MURA)	Ireland	$0.035B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.032B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.029B	0.00
Natural Alternatives (NAII)	United States	$0.028B	0.00
SCYNEXIS (SCYX)	United States	$0.028B	0.00
TherapeuticsMD (TXMD)	United States	$0.024B	0.00
Klotho Neurosciences (KLTO)	United States	$0.024B	0.00
Scienture Holdings (SCNX)	United States	$0.022B	0.00
Inotiv (NOTV)	United States	$0.021B	0.00
Liminatus Pharma (LIMN)	United States	$0.021B	0.00
VYNE Therapeutics (VYNE)	United States	$0.019B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.018B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.018B	0.00
Vyome Holdings (HIND)	United States	$0.018B	0.00
Vivos Therapeutics (VVOS)	United States	$0.018B	0.00
Cosmos Health (COSM)	United States	$0.018B	0.00
Mannatech (MTEX)	United States	$0.014B	0.00
Tempest Therapeutics (TPST)	United States	$0.013B	0.00
Traws Pharma (TRAW)	United States	$0.013B	0.02
CASI Pharmaceuticals (CASI)	China	$0.013B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.013B	0.00
BioLineRx (BLRX)	Israel	$0.012B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.012B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.011B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.010B	0.00
Mangoceuticals (MGRX)	United States	$0.010B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.010B	0.00
BioVie (BIVI)	United States	$0.010B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.009B	0.00
Nuvilex (PMCB)	United States	$0.009B	0.00
Ainos (AIMD)	United States	$0.009B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.009B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.008B	0.00
Biomerica (BMRA)	United States	$0.008B	0.00
Salarius Pharmaceuticals (DCOY)	United States	$0.008B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.008B	0.00
Heatwurx (PCSA)	United States	$0.007B	0.00
Aptorum Group (APM)	United Kingdom	$0.007B	0.00
Indaptus Therapeutics (INDP)	United States	$0.006B	0.00
Redhill Biopharma (RDHL)	Israel	$0.006B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.006B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.006B	0.00
Xenetic Biosciences (XBIO)	United States	$0.005B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.004B	0.00
Clearmind Medicine (CMND)	Canada	$0.004B	0.00
Lyra Therapeutics (LYRA)	United States	$0.004B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.003B	0.00
Jaguar Animal Health (JAGX)	United States	$0.003B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.002B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.002B	0.00
CDT Equity (CDT)	United States	$0.002B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.002B	0.00
PainReform (PRFX)	Israel	$0.002B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.001B	0.00
SciSparc (SPRC)	Israel	$0.001B	0.00
Aditxt (ADTX)	United States	$0.001B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00